
By Tara Bruner Autoimmune diseases affect more than 15 million people [1] in the U.S. alone yet remain chronically underdiagnosed. …

By Holly Thomas, Associate Vice-President Specialty Care at Lilly UK and Ireland Immunology care in the UK is at a …

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A …